IP Library Patent Application 18602643
Patent Application
App. No. 18/602,643

FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/602,643
Abstract

Compositions include a curing agent of a fluorinated resorcinol or hydroquinone of Formula 1: R 1 and R 5 are independently H, halogen, optionally partially or fully halogenated C 1-18 alkyl, optionally partially or fully halogenated C 1-18 alkoxy, or X. R 2 -R 4 are independently OH, H, halogen, optionally partially or fully halogenated C 1-18 alkyl, optionally partially or fully halogenated C 1-18 alkoxy, or X. At least one of R 2 , R 3 , and R 4 is OH. Not more than 3 of R 1 -R 5 are halogen. X is Formula 2 or Formula 3 as disclosed herein. Curable fluoroelastomer compositions, fluoroelastomer masterbatches, curing agent and curing accelerator mixtures, salts, and methods of curing a polyhydroxy-curable fluoroelastomer including a curing agent of a fluorinated resorcinol or hydroquinone of Formula 1 are also disclosed herein.

Claims (36)

1 . A curable fluoroelastomer composition comprising:

a polyhydroxy-curable fluoroelastomer;

a curing agent of Formula 1:

wherein R 1 and R 5 are independently selected from the group consisting of H, halogen, C 1-18 alkyl which may be partially or fully halogenated, C 1-18 alkoxy which may be partially or fully halogenated, and X;

wherein R 2 , R 3 , and R 4 are independently selected from the group consisting of OH, H, halogen, C 1-18 alkyl which may be partially or fully halogenated, C 1-18 alkoxy which may be partially or fully halogenated, and X,

with the proviso that at least one of R 2 , R 3 , and R 4 is OH;

with the proviso that not more than 3 of R 1 , R 2 , R 3 , R 4 , and R 5 are halogen;

wherein X is selected from the group consisting of Formula 2 and Formula 3:

wherein R 6 , R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of H, C 1-18 alkyl which may be partially or fully halogenated, C 1-18 alkoxy which may be partially or fully halogenated, partially or fully fluorinated phenyl, acetyl or methylsulfonyl which may be alkyl- or aryl-substituted or partially or fully halogenated, nitro, nitrile, and halogen, with the proviso that N may be substituted at exactly one of C 2 , C 3 , or C 4 in which case respective R 6 , R 7 , or R 8 is absent;

wherein R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , and R 18 are independently selected from the group consisting of H, C 1-18 alkyl which may be partially or fully halogenated, C 1-18 alkoxy which may be partially or fully halogenated, nitro, nitrile, and halogen with the proviso that one of R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , and R 18 is a single bond to —(Y) n —;

wherein Y is selected from the group consisting of —SO 2 —, —C(O)—, —C(CF 3 ) 2 —, and —O—; and

wherein n is 0 or 1;

with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , and R 5 , is fluorine, a fluorine-containing C 1-18 alkyl, a fluorine-containing C 1-18 alkoxy, or X;

with the proviso that, when X is present and none of R 1 , R 2 , R 3 , R 4 , and R 5 is fluorine, a fluorine-containing C 1-18 alkyl, or a fluorine-containing C 1-18 alkoxy, at least one of R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , and R 18 is fluorine, a fluorine-containing C 1-18 alkyl, or a fluorine-containing C 1-18 alkoxy; and

an acid acceptor.

2 . The curable fluoroelastomer composition of claim 1 , wherein at least one of R 1 and R 5 is H.

3 . The curable fluoroelastomer composition of claim 1 , wherein at least one of R 1 , R 2 , R 3 , R 4 , and R 5 is H when it is an adjacent substituent to OH.

4 . The curable fluoroelastomer composition of claim 1 , wherein no more than one of R 1 , R 2 , R 3 , R 4 , and R 5 is X.

5 . The curable fluoroelastomer composition of claim 1 , wherein no more than 2 of R 1 , R 2 , R 3 , R 4 , and R 5 are halogen.

6 . The curable fluoroelastomer composition of claim 1 , wherein only one of R 2 , R 3 , and R 4 is OH.

7 . The curable fluoroelastomer composition of claim 6 , wherein either R 2 or R 4 is OH.

8 . The curable fluoroelastomer composition of claim 1 , wherein R 1 and R 5 are selected from the group consisting of H, fluorine, C 1-18 alkyl which may be partially or fully fluorinated, C 1-18 alkoxy which may be partially or fully fluorinated, and X; and wherein R 2 , R 3 , and R 4 are independently selected from the group consisting of OH, H, fluorine, C 1-18 alkyl which may be partially or fully fluorinated, C 1-18 alkoxy which may be partially or fully fluorinated, and X.

9 . The curable fluoroelastomer composition of claim 1 , wherein one of R 1 , R 2 , R 3 , R 4 , and R 5 is X, and X is Formula 2.

10 . The curable fluoroelastomer composition of claim 9 , wherein R 6 , R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of H, fluorine, C 1-6 alkyl which may be partially or fully fluorinated, and C 1-6 alkoxy which may be partially or fully fluorinated, and at least one of R 6 , R 7 , R 8 , R 9 , and R 10 is fluorine, C 1-6 alkyl which may be partially or fully fluorinated, or C 1-6 alkoxy which may be partially or fully fluorinated.

11 . The curable fluoroelastomer composition of claim 9 , wherein R 6 , R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of H, fluorine, perfluoromethyl, and perfluoromethoxy, and at least one of R 6 , R 7 , R 8 , R 9 , and R 10 is fluorine, perfluoromethyl, or perfluoromethoxy.

12 . The curable fluoroelastomer composition of claim 1 , wherein n is 0.

13 . The curable fluoroelastomer composition of claim 1 , wherein —Y— is —O—.

14 . The curable fluoroelastomer composition of claim 1 , wherein the curing agent is selected from the group consisting of:

15 . The curable fluoroelastomer composition of claim 1 containing about 0.1 to about 10 parts by weight of said curing agent per 100 parts by weight of said polyhydroxy-curable fluoroelastomer.

16 . The curable fluoroelastomer composition of claim 1 , wherein the polyhydroxy-curable fluoroelastomer is a copolymer of hexafluoropropylene and vinylidene fluoride.

17 . The curable fluoroelastomer composition of claim 1 , wherein the polyhydroxy-curable fluoroelastomer is a terpolymer of hexafluoropropylene, vinylidene fluoride, and tetrafluoroethylene.

18 . The curable fluoroelastomer composition of claim 1 , wherein the acid acceptor is selected from the group consisting of powdered magnesium oxide, calcium hydroxide, and a combination thereof.

19 . The curable fluoroelastomer composition of claim 1 , wherein the curable fluoroelastomer composition is free of 2,2-bis(4-hydroxyphenyl)hexafluoropropane.

20 . The curable fluoroelastomer composition of claim 1 further comprising a curing accelerator.

21 . The curable fluoroelastomer composition of claim 20 , wherein the curing accelerator is in the form of a pre-reacted salt with a portion of the curing agent.

22 . The curable fluoroelastomer composition of claim 21 , wherein the curing agent is present in a threefold to fourfold molar excess of the curing accelerator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2024
From: SHTAROV, ALEXANDER BORISOVICH; MORKEN, PETER A.; MATSNEV, ANDRII; KO, SEUNG KYUNG
To: CHEMOURS COMPANY FC, LLC, THE
Reel/Frame 067580/0599 →